Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome

Podobne zapisy

• COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
  od: Moin, Abu Saleh Md, i wsp.
  Wydane: (2020)
• Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
  od: Moin, Abu Saleh Md, i wsp.
  Wydane: (2021)
• The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome
  od: Moin, Abu Saleh Md, i wsp.
  Wydane: (2021)
• Vitamin D association with coagulation factors in polycystic ovary syndrome is dependent upon body mass index
  od: Moin, Abu Saleh Md, i wsp.
  Wydane: (2021)
• Renin-Angiotensin System overactivation in polycystic ovary syndrome, a risk for SARS-CoV-2 infection?
  od: Moin, Abu Saleh Md, i wsp.
  Wydane: (2020)